Select Page

Bylaws

1. Name
The name of the division is the Clinical Pharmacology Division of the International Union of Basic and Clinical Pharmacology. It is constituted under Section 4 of the old statutes of IUPHAR (Section V3 of the 2002 revised statutes).

2. Aims and functions of the Clinical Pharmacology Division
The object of the Division is to encourage the organization of international co-operation in clinical pharmacology and therapeutics by:

a. Promoting co-operation between clinical pharmacologists throughout the world
b. Sponsoring international and regional programmes of education and research in clinical pharmacology
c. Acting as a body through which clinical pharmacologists can make known their opinions to the general assembly of IUPHAR and the scientific community at large.

3. Membership
The membership of the Clinical Pharmacology Division will comprise of clinical pharmacologists who are members of a national, regional or international society of pharmacology, clinical pharmacology or related disciplines. Societies of Clinical Pharmacology members of IUPHAR may also seek affiliation to the Clinical Division.

4. Executive Board


a. The officers of the Council will be elected by the vote at a properly constituted general meeting normally held at a World Conference on Clinical Pharmacology and Therapeutics and/or IUPHAR World Conference at 4 year intervals
b. The Council shall consist of a Chairman, Vice-Chairman, Secretary, Treasurer, no more than ten Councillors and the past-Chairman (ex officio). Election shall be from a slate of nominees presented by the Council. Additional nominations may also be initiated from the floor at the general meetings.In the event that the office of Chairman becomes vacant between General assemblies of the Council, the Vice-Chairman in the sequence shall succeed to that office for the rest of its term. In the event that either of the offices of Secretary General or Treasurer becomes vacant between General Assemblies of the Council, the Chairman with the concurrence of the Executive Committee shall appoint one of the Councillors to fill the office for the rest of its term. Under any of the above circumstances or if other positions on the Executive Committee become vacant, the Executive Committee shall be reduced in number until such time as a new Committee is elected
c. The Council may raise and maintain such funds as it deems necessary to carry out the Division’s activities
d. The Council may establish and determine the membership of Sub-Committees concerned with special education or research activities or scientific meetings. The Council may also discontinue any Sub-Committee. Sub-Committee Chairmen need not to be elected as Councillors to serve in that capacity
e. Members of the Council shall be elected for one term of office of four years and may be re-elected for a second term of four years. After completion of two consecutive terms, if not elected to the post of Chairman, Vice-Chairman, Secretary or Treasurer, members of the Council are not eligible for a third four year term until after an interval of at least four years.

A general meeting of the Division will normally take place at each World Conference on Clinical Pharmacology and Therapeutics and/or the World Conference of IUPHAR. The general meeting will receive a report from the Council and will elect the next Council